TransForm Pharmaceuticals, Inc. engages in the development of pharmaceutical products. It also develops solutions that address research and development problems in the biological and vaccines areas.
Vaccines
Sanofi-aventis U.S. is part of a leading global pharmaceutical company that discovers, develops, produces and markets innovative therapies that enhance people’s lives.
Baxter International Inc. is a global healthcare company that, through its subsidiaries assists healthcare professionals and their patients with treatment of complex medical conditions including hemophilia, immune disorders, kidney disease, trauma and other conditions.
Pulmatrix is developing new breakthrough therapies with the vision of fundamentally changing the way we treat, prevent and control infectious and progressive respiratory diseases.
Liquidia Technologies is developing engineered particle-based vaccines and therapeutics that have the potential to dramatically improve the quality of human life. Utilizing a novel technology known as the PRINT® platform, Liquidia is creating rationally-design carriers for improved delivery of small molecule and biological cargos.